Randomized Trial Comparing Water Vapour Thermal Therapy Rezum and Prostatic Urethral Lift UroLift for Men With Benign Prostatic Hyperplasia Evaluating Effectiveness and Cost
Led by Chinese University of Hong Kong · Updated on 2026-10-27
120
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a randomized controlled trial to compare two treatments for men with benign prostatic hyperplasia BPH. The study uses a non-inferiority design to evaluate the effectiveness and cost efficiency of water vapour thermal therapy REZUM versus prostatic urethral lift UroLift in male participants aged 50 years or older with symptomatic BPH.
Participants will be randomly assigned to one of two groups one receiving the REZUM water vapour treatment and the other receiving the UroLift prostatic urethral lift procedure. Both are device-based treatments aimed at improving urinary symptoms caused by BPH. The study measures outcomes at baseline and at 3, 6, and 12 months after treatment.
During the trial, participants will be monitored through various assessments including symptom scores IPSS, quality of life questionnaires, uroflowmetry tests for voiding function, and erectile function evaluations. Researchers will also track hospital stays, catheter use after surgery, complication rates, unplanned readmissions, and overall costs related to the procedures and hospitalization. Follow-up will extend up to 12 months post-treatment to assess changes and safety.
CONDITIONS
Brief Title
Comparing Rezum and Urolift
Research Team
P
Peter Ka-Fung CHIU
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Symptomatic benign prostatic hyperplasia with International Prostate Symptom Score of 13 or higher
Prostate volume between 30 and 80 milliliters
You will not qualify if you...
History or high suspicion of prostate cancer
Current urinary tract infection
Refractory urinary retention or post-void residual volume greater than or equal to 250 mL
Intravesical prostatic protrusion greater than 10 mm
Prior prostate surgery
Known or suspected allergy to nickel, titanium, or polyester/polypropylene
Urethral stricture, meatal stenosis, or bladder neck contracture
Neurogenic bladder or sphincter abnormalities
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to 12 months follow-up post-treatment
Participants receive either the REZUM water vapour thermal therapy or the UroLift prostatic urethral lift procedure as assigned.
Visits at baseline, 3 months, 6 months, and 12 months after treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of Finasteride Treatment for Benign Prostatic Hyperplasia in Men 50 and Older
Using Gene and MRI Tests to Predict Treatment Response
Study of Lingze Tablets Plus Tamsulosin to Improve Sleep and Nighttime Urination in Men After Prostate Surgery
Study to Test the Safety and Effectiveness of the FloStent Device in Men Over 45 With Benign Prostatic Hyperplasia Symptoms
Study of the Beacon Robot-Assisted Platform for Holmium Laser Surgery in Men with Benign Prostatic Enlargement
Testing a Smart Wearable Electrical Impedance Tomography Device to Monitor Urination in Men with Benign Prostatic Hyperplasia
Safety and Pharmacokinetics Study of AD-116 and AD-1161 in Healthy Adult Men with Benign Prostatic Hyperplasia
Evaluation of the Glean Urodynamics System for Ambulatory Lower Urinary Tract Monitoring in Adults
Comparing Prostate Artery Embolization to Surgery for Treating Enlarged Prostate Symptoms
Randomized Study on Treatment Safety, Recovery, and Quality of Life
International Registry to Collect Data on Treatments and Outcomes for Men with Benign Prostatic Hyperplasia
Randomized Trial Comparing Water Vapour Thermal Therapy Rezum and Prostatic Urethral Lift UroLift for Men With Benign Prostatic Hyperplasia Evaluating Effectiveness and Cost
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Kevin T McVary, Marc C Gittelman, Kenneth A Goldberg...
Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study.
Item Response Theory Modeling of the International Prostate Symptom Score in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
Yassine Kamal Lyauk, Daniël M Jonker, Trine Meldgaard Lund...
Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Kevin T McVary, Steven N Gange, Marc C Gittelman...
Short-stay transurethral prostate surgery: A randomized controlled trial comparing transurethral resection in saline bipolar transurethral vaporization of the prostate with monopolar transurethral resection.
Chi-hang Yee, Joseph Hon-ming Wong, Peter Ka-fung Chiu...